Darren McGuire (Cardiologist at UT Southwestern and Senior Editor of Diabetes and Vascular Disease Research ) to discuss important trial data on GLP-1 RAs in patients with heart disease, as well as recent professional society guidelines on their use
The FDA has given its approval for semaglutide use, recognizing its ability to help patients 12 years or older who are significantly overweight achieve better control over their eating habits
Nourish has raised a $100 million Series C round as the fast-growing virtual metabolic health company looks to scale an AI-driven care model built around dietitians, behavior change, and integrated GLP-1 management at a time when employers, insurers, and healthcare systems are searching for ways to control the soaring costs of chronic disease
In your brain's hypothalamusthe appetite control centerGLP-1 activates satiety pathways that suppress hunger signals and increase feelings of fullness after modest food intake
These are the effects of L-Carnitine that are theorized or that make sense, or that there is some evidence to support, but that studies have not yet formalized or proven
